AAAAAA
Results: 1-25/51
Authors:
HAY CRM
Citation: Crm. Hay, FACTOR-VIII INHIBITORS IN MILD AND MODERATE-SEVERITY HEMOPHILIA-A, Haemophilia, 4(4), 1998, pp. 558-563
Authors:
STANWORTH SJ
BOLTON MJ
HAY CRM
SHIACH CR
Citation: Sj. Stanworth et al., INCREASED BLEEDING IN HIV-POSITIVE HEMOPHILIACS TREATED WITH ANTIRETROVIRAL PROTEASE INHIBITORS, Haemophilia, 4(2), 1998, pp. 109-114
Authors:
HAY CRM
LUDLAM CA
COLVIN BT
HILL FGH
PRESTON FE
WASSEEM N
BAGNALL R
PEAKE IR
BERNTORP E
BUNSCHOTEN EPM
FIJNVANDRAAT K
KASPER CK
WHITE G
SANTAGOSTINO E
Citation: Crm. Hay et al., FACTOR-VIII INHIBITORS IN MILD AND MODERATE-SEVERITY HEMOPHILIA-A, Thrombosis and haemostasis, 79(4), 1998, pp. 762-766
Authors:
HAY CRM
LUDLAM CA
LOWE GDO
MAYNE EE
LEE RJ
PRESCOTT RJ
LEE CA
Citation: Crm. Hay et al., THE EFFECT OF MONOCLONAL OR ION-EXCHANGE PURIFIED FACTOR-VIII CONCENTRATE ON HIV DISEASE PROGRESSION - A PROSPECTIVE COHORT COMPARISON, British Journal of Haematology, 101(4), 1998, pp. 632-637
Authors:
ALEDORT LM
HAY CRM
Citation: Lm. Aledort et Crm. Hay, PORCINE FACTOR-VIII - ITS ROLE IN THE MANAGEMENT OF CONGENITAL AND ACQUIRED INHIBITORS - PROCEEDINGS OF A WORKSHOP HELD AT THE WORLD-FEDERATION-OF-HEMOPHILIA CONGRESS DUBLIN, IRELAND, 28 JUNE 1996 - FOREWORD, Haemophilia, 3, 1997, pp. 1-1
WORKSHOP III - PORCINE FACTOR-VIII - CONTINUOUS-INFUSION, IMMUNE TOLERANCE INDUCTION AND PROPHYLAXIS
Authors:
HAY CRM
DIMICHELE D
RIVARD G
RUBINGER M
GRIBBLE J
Citation: Crm. Hay et al., WORKSHOP III - PORCINE FACTOR-VIII - CONTINUOUS-INFUSION, IMMUNE TOLERANCE INDUCTION AND PROPHYLAXIS, Haemophilia, 3, 1997, pp. 24-30
Authors:
LUDLAM CA
HAY CRM
DOLAN G
Citation: Ca. Ludlam et al., TREATMENT FOR HEMOPHILIA BY POSTCODE, BMJ. British medical journal, 314(7082), 1997, pp. 749-749
Authors:
CUMMING AM
KEENEY S
SALDEN A
SHANKS D
HAY CRM
Citation: Am. Cumming et al., POTENTIAL MISDIAGNOSIS OF FV LEIDEN - COMPARISON OF 2 GENOTYPIC TESTING STRATEGIES, Thrombosis and haemostasis, 1997, pp. 61-61
Authors:
HAY CRM
NEGRIER C
LUDLAM CA
Citation: Crm. Hay et al., TREATMENT OF ACQUIRED HEMOPHILIA WITH RECOMBINANT FACTOR VIIA, Thrombosis and haemostasis, 1997, pp. 204-204
Authors:
HAY CRM
LUDLAM CA
LOWE GDO
MAYNE EE
LEE RJ
PRESCOT RJ
LEE CA
Citation: Crm. Hay et al., THE EFFECT OF MONOCLONAL OR ION EXCHANGE-PURIFIED FACTOR-VIII CONCENTRATE ON HIV DISEASE PROGRESSION - A PROSPECTIVE-STUDY, Thrombosis and haemostasis, 1997, pp. 2078-2078
Authors:
OLLIER W
HAY CRM
PEPPER L
CUMMING A
KEENEY S
GOODEVE AC
PRESTON FE
COLVIN BT
HILL FGH
PEAKE IR
Citation: W. Ollier et al., HLA CLASS-II PROFILE - A DETERMINANT OF INHIBITOR DEVELOPMENT IN SEVERE HEMOPHILIA-A, Thrombosis and haemostasis, 1997, pp. 2657-2657
Authors:
KEENEY S
CUMMING AM
HAY CRM
Citation: S. Keeney et al., SCREENING FOR MUTATIONS IN VON-WILLEBRAND DISEASE TYPE-1, Thrombosis and haemostasis, 1997, pp. 2663-2663
Authors:
CUMMING AM
KEENEY S
SHANKS D
HAY CRM
Citation: Am. Cumming et al., VON-WILLEBRAND-DISEASE (VWD) TYPE 2N IN PATIENTS DIAGNOSED TO HAVE HEMOPHILIA-A OR VWD TYPE-1, Thrombosis and haemostasis, 1997, pp. 2682-2682
Authors:
HAY CRM
NEGRIER C
LUDLAM CA
Citation: Crm. Hay et al., THE TREATMENT OF BLEEDING IN ACQUIRED HEMOPHILIA WITH RECOMBINANT FACTOR VIIA - A MULTICENTER STUDY, Thrombosis and haemostasis, 78(6), 1997, pp. 1463-1467
Authors:
CUMMING AM
KEENEY S
SALDEN A
SHANKS D
HAY CRM
Citation: Am. Cumming et al., POTENTIAL MISDIAGNOSIS OF FACTOR-V-LEIDEN - A COMPARISON OF 2 GENOTYPING TECHNIQUES, Thrombosis and haemostasis, 77(6), 1997, pp. 1217-1217
Authors:
HAY CRM
OLLIER W
PEPPER L
CUMMING A
KEENEY S
GOODEVE AC
COLVIN BT
HILL FGH
PRESTON FE
PEAKE IR
Citation: Crm. Hay et al., HLA CLASS-II PROFILE - A WEAK DETERMINANT OF FACTOR-VIII INHIBITOR DEVELOPMENT IN SEVERE HEMOPHILIA-A, Thrombosis and haemostasis, 77(2), 1997, pp. 234-237
Authors:
SALDEN A
KEENEY S
HAY CRM
CUMMING AM
Citation: A. Salden et al., THE C677T MTHFR VARIANT AND THE RISK OF VENOUS THROMBOSIS, British Journal of Haematology, 99(2), 1997, pp. 472-472
Authors:
CUMMING AM
KEENEY S
SALDEN A
BHAVNANI M
SHWE KH
HAY CRM
Citation: Am. Cumming et al., THE PROTHROMBIN GENE G20210A VARIANT - PREVALENCE IN A UK ANTICOAGULANT CLINIC POPULATION, British Journal of Haematology, 98(2), 1997, pp. 353-355
Authors:
HAY CRM
LEE CA
SAVIDGE G
Citation: Crm. Hay et al., A POSTMARKETING SAFETY AND EFFICACY ASSESSMENT OF A MONOCLONAL-ANTIBODY PURIFIED HIGH-PURITY FACTOR-VIII CONCENTRATE, Haemophilia, 2(1), 1996, pp. 32-36
Authors:
HAY CRM
COLVIN BT
LUDLAM CA
HILL FGH
PRESTON FE
Citation: Crm. Hay et al., RECOMMENDATIONS FOR THE TREATMENT OF FACTOR-VIII INHIBITORS - FROM THE UK-HEMOPHILIA-CENTER DIRECTORS ORGANIZATION INHIBITOR WORKING PARTY, Blood coagulation & fibrinolysis, 7(2), 1996, pp. 134-138
Authors:
HAY CRM
DOUGHTY HI
SAVIDGE GF
Citation: Crm. Hay et al., CONTINUOUS-INFUSION OF FACTOR-VIII FOR SURGERY AND MAJOR BLEEDING, Blood coagulation & fibrinolysis, 7, 1996, pp. 15-19
Authors:
HAY CRM
Citation: Crm. Hay, A MULTICENTER PROSPECTIVE COHORT STUDY OF IMMUNE FUNCTION IN PATIENTSTREATED WITH MONOCLONALLY IMMUNOPURIFIED OR RESIN-PURIFIED SNBTS HIGH-POTENCY FACTOR-VIII CONCENTRATE, Transfusion science, 17(3), 1996, pp. 337-338
Authors:
HAY CRM
LOZIER JN
LEE CA
LAFFAN M
TRADATI F
SANTAGOSTINO E
CIAVARELLA N
SCHIAVONI M
FUKUI H
YOSHIOKA A
TEITEL J
MANNUCCI PM
KASPER CK
Citation: Crm. Hay et al., SAFETY PROFILE OF PORCINE FACTOR-VIII AND ITS USE AS HOSPITAL AND HOME-THERAPY FOR PATIENTS WITH HEMOPHILIA-A AND INHIBITORS - THE RESULTS OF AN INTERNATIONAL SURVEY, Thrombosis and haemostasis, 75(1), 1996, pp. 25-29
Authors:
KAMIGUTI AS
HAY CRM
ZUZEL M
Citation: As. Kamiguti et al., INHIBITION OF COLLAGEN-INDUCED PLATELET-AGGREGATION AS THE RESULT OF CLEAVAGE OF ALPHA(2)BETA(1)-INTEGRIN BY THE SNAKE-VENOM METALLOPROTEINASE JARARHAGIN, Biochemical journal, 320, 1996, pp. 635-641
Authors:
HAY CRM
LAURIAN Y
Citation: Crm. Hay et Y. Laurian, INDUCTION OF TOLERANCE USING PORCINE FACTOR-VIII, Vox sanguinis, 70, 1996, pp. 68-69